P: +1 917-388-1578
To commercialize innovative brain diagnostic solutions that apply cutting edge technologies and establish a new innovative norm for clinicians
Our Technology Roadmap
Portable, clinical-grade, easy-to-use diagnostic devices for remote/teleneurology settings
On Demand Data Exchange
Secure, cloud-based, highly scalable infrastructure to transmit patient data between neurologists and patients
(in active development)
A.I. Predictive Biomarkers
Artificial intelligence assisted diagnostic analysis to increase neurologist efficiency, consistency, and accuracy
(in active development)
EEG 2.0: The Next Gen Solution
Our first commercialized products aim to disrupt the slow, expensive and cumbersome EEG market with easy to use, economic and disposable substitutes that permit any medical professional, in any setting to diagnose patients remotely within minutes.
NeuroCap™ is a disposable, pre-gelled headset (19 channel, 22 electrode) that can be applied easily and quickly.
NeuroEEG™ is a modern, portable EEG system that fits in the palm of your hand.
Introduce pediatric version of NeuroCap, an easy to use disposable headset that overcomes the infection and inconvenience burden of conventional EEG pediatric products
Launch the next generation of NeuroCap and NeuroEEG products addressing long-term monitoring for improved prognosis and care management of epileptic seizure
We are working with current open source EEG resources to develop a machine learning algorithm that analyzes biomarkers and will have predictive capabilities for diagnosis of epilepsy, dementia, and Alzheimer’s
Case Study - Bergen Neurology Consultants uses MemoryMD’s EEG solutions to streamline practice and recoup revenue.
Case Study - Virginia Tech Sports Medicine Program Uses MemoryMD Solutions to Conduct Pioneering Concussion Research.
EEG is underused in the emergency department.
Safe Harbor: Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this presentation that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements.